Safety and efficacy of exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy: 52-week results of the DURATION-8 randomized controlled trial
Medications such as metformin, semaglutide, liraglutide , exenatide and tirzepatide in our patient base are clinically not usually showing lean loss outside of correction of hyperinsulinism- induced excess lean weight-related imbalances
Some preparations should be used within 30 days of opening
The slowed gastric emptying means large meals sit heavily and can cause discomfort
Health and Wellness: Oral and Injectable Medications for Type 2 Diabetes
As a company that has been providing science-backed, nutrient-dense products around the world since 1980, we stand by our position that foundational lifestyle changes and behaviors are crucial for sustained weight management and overall health